image
Akebia Therapeutics, Inc. AKBA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.79
-3.76 %
$ 391 M
Market Cap
-8.14
P/E
INCOME STATEMENT
195 M REVENUE
-33.49%
Growth Rates
1Year -33.49%
3Years -12.98%
5Years -1.30%
7Years 99.73%
10Years 0.00%
-46.3 M OPERATING INCOME
26.79%
Growth Rates
1Year 26.79%
3Years 50.28%
5Years 23.64%
7Years 14.32%
10Years -11.25%
-51.9 M NET INCOME
43.90%
Growth Rates
1Year 43.90%
3Years 48.65%
5Years 18.41%
7Years 12.83%
10Years -14.71%
EFFICIENCY
Earnings Waterfall Akebia Therapeutics, Inc.
image
Revenue 195 M
Cost Of Revenue 74.1 M
Gross Profit 120 M
Operating Expenses 201 M
Operating Income -46.3 M
Other Expenses 5.67 M
Net Income -51.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 194.6 292.6 213.6 295.3 335.0 207.7 178.0 1.5 0 0 0 0
GROSS PROFIT
Cost Of Revenue 74.1 84.8 153.4 295.9 145.3 7.7 0.6 115.8 96 K 23.3 0 0
Gross Profit 120.5 207.8 60.2 (0.6) 189.7 200.1 177.4 (114.2) 96 K (23.3) 0 0
OPERATING INCOME
Operating Expenses 201.1 271.0 325.5 375.8 476.0 378.2 257.9 138.0 61.5 37.9 15.9 8.5
Selling, General and Administrative Expenses 100.2 141.9 174.2 153.9 149.5 87.1 27.0 22.2 18.5 12.5 5.2 2.9
Research and Development Expenses 63.1 129.1 147.9 218.5 323.0 291.1 230.9 115.8 43.0 25.4 10.8 5.6
Operating Income (46.3) (63.2) (265.3) (376.4) (286.3) (178.1) (79.9) (136.5) (61.5) (37.9) (15.9) (8.5)
PRE-TAX INCOME
Interest Income Expense 6.0 15.7 19.9 8.9 1.4 6.2 0 0 0.5 0.2 0.7 (1.6)
Total Other Income (5.7) (13.4) (17.5) (5.6) 2 K 6.2 3.0 0.7 0.5 0.9 2.8 0.3
Pre-Tax Income (51.9) (92.6) (282.8) (383.5) (286.3) (171.9) (76.9) (135.7) (60.7) (37.0) (13.2) (8.2)
NET INCOME
Tax Provision 0 13.4 (38.0) (33.6) (6.6) (28.3) (2.8) (0.9) (0.5) (0.2) 1.8 1.6
Net Income (51.9) (106.0) (244.9) (349.9) (279.7) (171.9) (76.9) (135.7) (60.7) (37.0) (13.2) (8.2)
EPS 0.28 0.58 1.48 2.53 2.36 1.47 1.77 3.6 2.29 2.4 0.68 0.81